Ventricular Dysfunction Clinical Trial
— ALTERVOLOfficial title:
Hemodynamic Indices Predictive of a Beneficial Response to Fluid Expansion in Case of Hemodynamic Failure After Cardiac Surgery With Altered Preoperative Ejection Fraction (LVEF≤45%): Sensibility and Specificity of Respiratory Variations of Pulse Pressure (∆PP), Photoplethysmography (∆POP), Perfusion Index (PVI), Before and After Fluid Expansion.
Verified date | March 2016 |
Source | Rennes University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Low Cardiac Output Syndrome occurs frequently after cardiac surgery, especially when pre-operative LVEF is altered (LVEF≤45%). The correction of hemodynamic failure requires adapted treatments: fluid expansion and/or inotropic or vasoactive drugs. Predictive indices of a response to fluid challenge may allow an earlier hemodynamic optimization, which has not been showed until now when LVEF is altered.
Status | Completed |
Enrollment | 50 |
Est. completion date | December 2015 |
Est. primary completion date | December 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - patients >18 years old in the immediate post-operative period after cardiac surgery - ASA 1 - 3 - Pre-operative LVEF=45% - Sedated with Ramsay score: 6 - Mechanically ventilated with tidal volume at 8ml/kg, PEEP at 0mmHg, I/Eat 0,5 - With hemodynamic failure: SAP=90mmHg and/or inotropic or vasoactive drug started in the operating room and/or clinical sign of shock and/or CI =2,3l/min/m2 - Affiliation to Health Insurance - Consent form signed Exclusion Criteria: - Cardiac arrhythmia: frequent atrial or ventricular extra systoles, atrial fibrillation - Intracardiac shunt - Weight less than 50 kg - History of central nervous system illness - Pulmonary oedema (clinical and/or radiological and/or wedge pressure>18mmHg) - Right ventricular failure suspected (CVP> wedge pressure) or diagnosed (trans thoracic and/or transesophageal echocardiography) - Acute kidney injury with oligoanuria - Severe post operative bleeding (chest tubes volume of >200ml/h for 3 hours or more) - Severe hypoxia (PaO2/FIO2< 100) - Administrative control (patient under guardianship or curatorship) |
Country | Name | City | State |
---|---|---|---|
France | Rennes University Hospital | Rennes | Brittany |
Lead Sponsor | Collaborator |
---|---|
Rennes University Hospital |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Measure of ?PP, ?POP, PVI and Cardiac index (CI) | To assess the sensibility and specificity of ?PP, ?POP, PVI, after fluid expansion in case of hemodynamic failure in the immediate post-operative period after cardiac surgery, when pre-operative LVEF is altered. | 2 hours | |
Secondary | Measure of Systolic, diastolic and mean arterial pressure (SAP, DAP, MAP), Central venous pressure (CVP) and wedge pressure. | Secondary objectives : Early optimization of hemodynamics after cardiac surgery, To determine optimal threshold for ?PP, ?POP and PVI, To compare dynamic (?PP, ?POP and PVI) with static (central venous pressure: CVP, wedge pressure) indices |
2 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03799133 -
Safety and Efficacy of the Gastric Reactance (XL) in Patients Post-operated of Elective Cardiac Surgery
|
N/A | |
Not yet recruiting |
NCT02784912 -
Biomarkers in Risk Stratification of Sustainted Ventricular Tachycardia or Electrical Storm After Ablation
|
N/A | |
Completed |
NCT00982397 -
Safety and Clinical Performance of the Protecta ICD and CRT-D
|
N/A | |
Completed |
NCT00187252 -
Mascot Study: Management of Atrial Fibrillation (AF) Suppression in AF-Heart Failure (HF) COmorbidity Therapy
|
N/A | |
Recruiting |
NCT04848844 -
The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R)
|
||
Recruiting |
NCT05851053 -
Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study
|
||
Recruiting |
NCT02644850 -
Comparison of Gated Blood-pool SPECT and Echocardiogram for Ventricular Function
|
N/A | |
Terminated |
NCT00524862 -
Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death
|
N/A | |
Completed |
NCT00526162 -
ConsultaTM CRT-D Clinical Evaluation Study
|
N/A | |
Withdrawn |
NCT00166010 -
Effects of Nesiritide in Pediatric Patients With Heart Failure
|
N/A | |
Completed |
NCT00370643 -
Glucose Control in Open Heart Surgery
|
Phase 1 | |
Not yet recruiting |
NCT04068116 -
Impact of Ischemic Post-conditioning
|
N/A | |
Enrolling by invitation |
NCT03701997 -
Registry to Monitor Berlin Heart EXCOR® Pediatric VAD as a Bridge to Cardiac Transplantation.
|
||
Completed |
NCT02497950 -
HeartMate 3 ELEVATE™ Registry
|
||
Recruiting |
NCT05934071 -
Effects of the Sodium-glucose Cotransporter 2 Inhibitors+Sacubitril/Valsartan Therapy in Patients With HFrEF.
|
||
Recruiting |
NCT02816047 -
Austrian Wearable Cardioverter Defibrillator Registry
|
||
Completed |
NCT04634708 -
The Use of the EXCOR Active Driving Unit for Mobilization of Pediatric Patients With Ventricular Assist Device Support
|
||
Terminated |
NCT02820441 -
Benefit of One Month Zopiclone Intake on Adaptative Servoventilation Compliance
|
Phase 4 | |
Completed |
NCT00893360 -
CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction
|
Phase 1 | |
Completed |
NCT01452165 -
Peripheral Artery Disease in Vastmanland
|